Latest News

1News Report – Medsafe Approves 10 Minute Ocrevus Injection

April 30, 2025 | Advocacy, Life with MS, Media, News, Treatments

Watch Graham Walker, person with MS, President of MS Taranaki and Co-Vice President of MSNZ discuss the life-changing news that Medsafe has approved the 10 minute Ocrevus injection, accompanied with comments from Amanda Rose, MSNZ National Manager on 1News, 29th […]


Medsafe Approves 10 Minute Ocrevus Injection; TVNZ Breakfast Interview with Graham Walker

April 29, 2025 | Life with MS, Media, Treatments

Watch Graham Walker, President of MS Taranaki and Co Vice-President of MSNZ, discuss the newly approved 10 minute Ocrevus injection with Jenny-May on TVNZ’s Breakfast show. Click here: https://youtu.be/powx9Ukm3Dw We encourage those with lived experience to provide their stories to […]


Ocrelizumab Subcut Receives Medsafe Registration as Pressure Mounts to Fund Wider Range of MS Treatment Options

April 24, 2025 | Advocacy, Life with MS, News, Treatments

Photo by Kristine Wook, Unsplash. Medsafe have approved the registration of Ocrevus ® Subcutaneous (SC) (ocrelizumab and hyaluronidase) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). The announcement on […]


Ocrevus for PPMS – Your Questions Answered

September 14, 2023 | Treatments

  Here’s what you need to know about Ocrevus (ocrelizumab) for Primary Progressive MS. Download PDF copy here: PPMS Ocrevus FAQ – 13 September 2023.   What medicines are available to treat Primary Progressive Multiple Sclerosis (PPMS)?  There is only […]